Tyrosinemias - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Disease Reportstyrosinemias

MeSH D020176 - tyrosinemias

Favorite

Competitive Landscape

Events Timeline

Commercial

Clinical Trials

Competitive landscape

D020739:Metabolic brain diseases inborn

0 Companies

0 Drugs

Success rate

D000592:Inborn errors amino acid metabolism

$

Success rate

Tyrosinemias

$

Success rate

Events Timeline

Commercial

Company Name	Drug Name	Trade Name	Patent Expires	Approval Date	Revenue	Period
Allergan	Folic acid, Dexpanthenol, Ascorbic acid, Cyanocobalamin, Ergocalciferol, Vitamin a, Biotin, Niacinamide, Pyridoxine, Riboflavin, Thiamine	Mvc		1985-08-08
APP Pharmaceuticals	Folic acid, Dexpanthenol, Ascorbic acid, Cyanocobalamin, Ergocalciferol, Vitamin a, Biotin, Niacinamide, Pyridoxine, Riboflavin, Thiamine	M.v.c. 9+		1985-08-08
Cycle Pharmaceuticals	Nitisinone	Nityr		2018-07-26
Eton Pharmaceuticals	Nitisinone	Nitisinone		2023-05-25
Hospira	Folic acid, Dexpanthenol, Ascorbic acid, Cyanocobalamin, Ergocalciferol, Vitamin a, Biotin, Niacinamide, Pyridoxine, Riboflavin, Thiamine, Phytonadione	M.v.i.		1985-08-08
Hospira	Folic acid, Ascorbic acid, Cyanocobalamin, Ergocalciferol, Phytonadione, Vitamin a, Biotin, Niacinamide, Pantothenic acid, Pyridoxine, Riboflavin, Thiamine	Vitaped		1993-12-29
Medunik	Nitisinone	Nitisinone		2022-05-26
Novitium Pharma	Nitisinone	Nitisinone		2019-08-26
Orphan Medical	Nitisinone	Orfadin		2002-01-18

1

2

>

Clinical Trials

Historical Success Rate

Phase 1

100%

1/1

Phase 2

0%

0/0

Phase 3

100%

4/4

Approved: 3Overall Success rate: 0%

All Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Company name

Phase 1

Phase 2

Phase 3

Phase 4

Drug Name

Ergocalciferol,

Cycle Pharmaceuticals

McGuff Pharmaceuticals

Ergocalciferol,

Taro Pharmaceutical

1

2

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use